Progress and Hurdles for Follow-on Biologics

被引：38

作者：

Sarpatwari, Ameet ^{[1
]}

Avorn, Jerry

Kesselheim, Aaron S.

机构：

[1] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2015年 / 372卷 / 25期

关键词：

D O I：

10.1056/NEJMp1504672

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2380 / 2382

页数：3

共 50 条

[41] Follow-on biologics: data exclusivity and the balance between innovation and competition
Grabowski, Henry
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (06) : 479 - 488
[42] Impact of variability on the choice of biosimilarity limits in assessing follow-on biologics
Zhang, Nan
Yang, Jun
Chow, Shein-Chung
Endrenyi, Laszlo
Chi, Eric
STATISTICS IN MEDICINE, 2013, 32 (03) : 424 - 433
[43] Biosimilar epoetins and other "follow-on'' biologics: Update on the European experiences
Jelkmann, Wolfgang
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (10) : 771 - 780
[44] Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products
J. Michael Nicholas
Drug information journal : DIJ / Drug Information Association, 2012, 46 : 197 - 206
[45] Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products
Nicholas, J. Michael
DRUG INFORMATION JOURNAL, 2012, 46 (02): : 197 - 206
[46] Experience of reviewing the follow-on biologics including Somatropin and erythropoietin in Japan
Arato, Teruyo
Yamaguchi, Teruhide
BIOLOGICALS, 2011, 39 (05) : 289 - 292
[47] The FDA and follow-on biologics - Navigating the issues surrounding biologics & likely outcome of FDA generic deliberation
Romza-Kutz, DJ
GENETIC ENGINEERING NEWS, 2006, 26 (06): : 8 - 9
[48] Progress in the radarsat follow-on constellation payload design
Allan, P. (allan.p@ems-t.ca), (International Astronautical Federation, IAF, 94bis Avenue de Suffren, Paris, 75015, France):
[49] Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
Sarpatwari, Ameet
Choudhry, Niteesh K.
Avorn, Jerry
Kesselheim, Aaron S.
PLOS MEDICINE, 2015, 12 (03)
[50] Coping with the regulatory realities of follow-on biologics and the nuances of US and European regulations
Falk J.I.
Davidson R.A.
Drug information journal : DIJ / Drug Information Association, 2010, 44 (2): : 137 - 145

← 1 2 3 4 5 →